Deferasirox 67877-0549
Product NDC
67877-0549- Manufacturer
- Ascend Laboratories, Llc
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 22, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210519
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 125 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
30 TABLET, FOR SUSPENSION in 1 BOTTLE (67877-549-30)